The Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Update

The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) was the target of a large increase in short interest in the month of February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Based on an average daily trading volume, of 1,970,000 shares, the days-to-cover ratio is currently 0.5 days. Approximately 2.5% of the shares of the stock are short sold.

Oncology Institute Price Performance

Shares of NASDAQ:TOI traded down $0.13 during midday trading on Monday, reaching $0.72. 303,987 shares of the company's stock traded hands, compared to its average volume of 854,746. The company has a fifty day simple moving average of $0.65 and a two-hundred day simple moving average of $0.41. Oncology Institute has a 1 year low of $0.13 and a 1 year high of $1.94. The company has a market cap of $54.70 million, a P/E ratio of -0.95 and a beta of 0.37. The company has a debt-to-equity ratio of 5.91, a quick ratio of 2.27 and a current ratio of 2.49.

Hedge Funds Weigh In On Oncology Institute

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. FreeGulliver LLC increased its stake in shares of Oncology Institute by 219.3% during the fourth quarter. FreeGulliver LLC now owns 600,747 shares of the company's stock worth $186,000 after purchasing an additional 412,578 shares in the last quarter. Tiff Advisory Services LLC boosted its position in Oncology Institute by 13.2% during the fourth quarter. Tiff Advisory Services LLC now owns 2,979,141 shares of the company's stock worth $921,000 after acquiring an additional 346,256 shares during the last quarter. Virtu Financial LLC purchased a new position in Oncology Institute in the 4th quarter worth approximately $41,000. Jane Street Group LLC boosted its holdings in shares of Oncology Institute by 613.6% during the 4th quarter. Jane Street Group LLC now owns 127,659 shares of the company's stock worth $39,000 after purchasing an additional 109,769 shares during the last quarter. Finally, HighTower Advisors LLC grew its position in shares of Oncology Institute by 190.8% in the third quarter. HighTower Advisors LLC now owns 81,362 shares of the company's stock valued at $27,000 after purchasing an additional 53,382 shares in the last quarter. 36.86% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Oncology Institute Company Profile

The Oncology Institute, Inc, an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services.